TNF and infection: Complete elimination of Mtb in a pulmonary TB progressive model of infection by gene therapy is unlikely, so another aim of the present work was to test a combined therapy with TNF plus second-line antibiotics to seek a faster bacterial clearance, that could shorten the time of therapy, and that could result in less secondary and toxic effects, preventing abandonment of treatment and the surge of drug resistance.